Wild-type p53 induces apoptosis in Hep3B through up-regulation of bax expression

Laboratory Investigation

Volumn 77, Issue 4, 1997, Pages 369-378

  Mitry, Ragai R ^a   Sarraf, Catherine E ^a   Wu, Chuan Ging ^b   Pignatelli, Massimo ^a   Habib, Nagy A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; DNA DEGRADATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL COUNT; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; PLOIDIES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030724069     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Aden DP, Fogel A, Plotkin S, Damjanov I, and Knowles BB (1979). Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 262:615-616.
2. Alison MR and Sarraf CE (1994). Liver cell death: Patterns and mechanisms. Gut 35:577-581.
3. Alison MR and Sarraf CE (1995). Apoptosis: Regulation and relevance to toxicology. Hum Exp Toxicol 14:234-247.
4. Baker SJ, Markowitz S, Fearon ER, Wilson JKV, and Vogelstein B (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
5. Bressac B, Galvin KM, Liang J, Isselbacher KJ, Wands JA, and Ozturk M (1990). Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:1973-1977.
6. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, and Wyllie AH (1993). Thymocyte apoptosis induced by p53-dependent and -independent pathways. Nature 362:849-852.
7. WAF1/CIP1 and the control of cell proliferation. In: Thomas NSB, editor. Apoptosis and cell cycle control in cancer. Oxford: βIOS Scientific Publishers, 65-75.
8. Finaly CA, Hinds PW, and Levine AJ (1989). The p53 protooncogene can act as a suppressor of transformation. Cell 57:1083-1093.
9. Hockenberry DM, Zutter M, Hickey W, Nahm M, and Korsmeyer SJ (1991). BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965.
10. Hollstein M, Sidransky D, Vogelstein B, and Harris CC (1991). p53 mutations in human cancers. Science 253:49-53.
11. Kerr JFR, Winterford CM, and Harmon BV (1993). Apoptosis. Cancer 73:2013-2026.
12. Kerr JFR, Wyllie AH, and Currie AR (1972). Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26:239-257.
13. Kocher TD and Wilson AC (1993). DNA amplification by the polymerase chain reaction. In: Brown TA, editor. Essential molecular biology: A practical approach, vol 2. Oxford: Oxford IRL Press, 185-207.
14. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
15. Lane DP (1992). p53, guardian of the genome. Nature 358: 15-16.
16. Lane DP and Crawford LV (1979). T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263.
17. Levine AJ, Chang A, Dittmer D, Notterman DA, Silver A, Thorn K, Welsh D, and Wu M (1994). The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69:409-416.
18. Lin K-T, Xue J-Y, Nomen M, Spur B, and Wong PY-K (1995). Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 270:16487-16490.
19. Lotze MT, Flickinger JC, and Carr BI (1993). Hepatobiliary neoplasms. In: DeVita VT Jr, Hellman S, and Rosenberg SA, editors. Cancer: Principles and practice of oncology. Philadelphia: Lippincott, 883-914.
20. Lowe SW, Earl Ruley H, Jacks T, and Housman DE (1993). p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
21. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liebermann DA, Hoffman B, and Reed JC (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
22. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, and Sikorska M (1993). Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679-3684.
23. Okuda K and Okuda H (1991). Primary liver cell carcinoma. In: McIntyre N, Benhamou J-P, Bircher J, Rizzetto M, and Rodes J, editors. Oxford textbook of clinical hepatology. Oxford: Oxford University Press, 1019-1053.
24. Oltvai ZN, Milliman CL, and Korsmeyer SJ (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74:609-619.
25. Oren M (1992). p53: The ultimate tumor suppressor gene? FASEB J 6:3169-3176.
26. Puisieux A, Ponchel F, and Ozturk M. (1993a). p53 as growth suppressor gene in HBV-related hepatocellular carcinoma cells. Oncogene 8:487-490.
27. Puisieux A, Galvin K, Troalen F, Bressac B, Macais C, Galun E, Ponchel F, Yakicier C, Ji J, and Ozturk M. (1993b). Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J 7:1407-1413.
28. Raff MC (1992). Social controls on cell survival and cell death. Nature 356:397-400.
29. Reed JC, Haldar S, Croce CM, and Cuddy MP (1990). Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts. Mol Cell Biol 10:4370-4374.
30. Rill DR, Moen RC, Buschle M, Bartholomew C, Foreman NK, Mirro J, Krance RA, Ihle JN, and Brenner Mk (1992). An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood 79:2694-2700.
31. Sambrook J, Fritsch EF, and Maniatis T (1989). Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Laboratory.
32. Selvakumaran M, Lin H-K, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, and Liebermann D (1994). Immediate early up-regulation of bax expression by p53 but not TGFβ1: A paradigm for distinct apoptotic pathways. Oncogene 9: 1791-1798.
33. Sherlock S and Dooley J (1993). Diseases of the liver and biliary system. Oxford: Blackwell Scientific Publications.
34. Solomon E, Borrow J, and Goddard AD (1991). Chromosome aberrations and cancer. Science 254:1153-1160.
35. Unsal H, Yakicier C, MarHais C, Kew M, Volkmann M, Zentgraf H, Isselbacher KJ, and Ozturk M (1994). Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci USA 91:822-826.
36. White E (1996). Life, death, and the pursuit of apoptosis. Genes Dev 10:1-15.
37. Williams GT (1991). Programmed cell death: Apoptosis and oncogenesis. Cell 65:1097-1098.
38. Wyllie AH, Kerr JFR, and Currie AR (1980). Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306.
39. + cytotoxic T cells. Cancer Res 53:3257-3261.
40. Yin C, Knudson CM, Korsmeyer SJ, and Van Dyke T (1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637-640.
41. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, and Oren M (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-247.